Recent Finacing
Recent Raise
Numab Therapeutics is a clinical-stage biopharma developing multispecific antibody therapeutics via its MATCH/Lambda-cap platforms (up to six specificities), advancing PD-L1×4-1BB×HSA trispecifics and inflammation/oncology programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
